Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 4:30 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | Rubric Capital Management LP | 10,400,000 9.030% | 10,400,000 (New Position) | View |
| 2024-07-23 08:23 am Sale | 13G | Coherus BioSciences Inc. CHRS | Temasek Holdings (Private) Ltd | 5,536,949 4.800% | -683,603 (-10.99%) | View |
| 2024-05-22 7:27 pm Sale | 13G | Coherus BioSciences Inc. CHRS | Temasek Holdings (Private) Ltd | 6,220,552 5.400% | -1,160,564 (-15.72%) | View |
| 2024-02-14 4:58 pm Sale | 13G | Coherus BioSciences Inc. CHRS | CITADEL ADVISORS LLC | 2,047,286 1.800% | -3,767,788 (-64.79%) | View |
| 2024-02-14 3:00 pm Sale | 13G | Coherus BioSciences Inc. CHRS | ALLIANCEBERNSTEIN L.P. | 156,000 0.100% | -6,023,005 (-97.48%) | View |
| 2024-02-13 5:02 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | VANGUARD GROUP INC | 10,357,412 9.300% | 4,541,530 (+78.09%) | View |
| 2024-01-24 09:46 am Purchase | 13G | Coherus BioSciences Inc. CHRS | BlackRock Inc. BLK | 12,074,695 10.800% | 428,860 (+3.68%) | View |
| 2024-01-22 2:08 pm Sale | 13G | Coherus BioSciences Inc. CHRS | STATE STREET CORP STT | 2,064,326 1.850% | -4,721,656 (-69.58%) | View |
| 2023-12-07 2:45 pm Sale | 13G | Coherus BioSciences Inc. CHRS | JPMORGAN CHASE & CO JPM | 124,796 0.100% | -5,538,974 (-97.80%) | View |
| 2023-10-06 2:34 pm Sale | 13G | Coherus BioSciences Inc. CHRS | BlackRock Inc. BLK | 11,645,835 10.900% | -2,433,066 (-17.28%) | View |
| 2023-05-19 09:15 am Purchase | 13G | Coherus BioSciences Inc. CHRS | CITADEL ADVISORS LLC | 5,815,074 6.200% | 5,815,074 (New Position) | View |
| 2023-02-14 2:31 pm Sale | 13G | Coherus BioSciences Inc. CHRS | PERCEPTIVE ADVISORS LLC | 0 0.000% | -5,407,798 (Position Closed) | View |
| 2023-02-13 7:15 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | ALLIANCEBERNSTEIN L.P. | 6,179,005 8.000% | 510,477 (+9.01%) | View |
| 2023-02-09 11:15 am Purchase | 13G | Coherus BioSciences Inc. CHRS | VANGUARD GROUP INC | 5,815,882 7.480% | 1,268,353 (+27.89%) | View |
| 2023-02-03 4:00 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | STATE STREET CORP STT | 6,785,982 8.720% | 2,964,862 (+77.59%) | View |
| 2023-01-26 08:52 am Unchanged | 13G | Coherus BioSciences Inc. CHRS | BlackRock Inc. BLK | 14,078,901 18.100% | 0 (Unchanged) | View |
| 2023-01-20 09:43 am Purchase | 13G | Coherus BioSciences Inc. CHRS | BlackRock Inc. BLK | 14,078,901 18.100% | 2,160,046 (+18.12%) | View |
| 2023-01-18 1:30 pm Sale | 13G | Coherus BioSciences Inc. CHRS | JPMORGAN CHASE & CO JPM | 5,663,770 7.200% | -691,417 (-10.88%) | View |
| 2022-02-14 6:33 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | PERCEPTIVE ADVISORS LLC | 5,407,798 7.000% | 735,962 (+15.75%) | View |
| 2022-02-14 2:45 pm Purchase | 13G | Coherus BioSciences Inc. CHRS | ALLIANCEBERNSTEIN L.P. | 5,668,528 7.400% | 1,012,629 (+21.75%) | View |